Denial Arbitrage Engine
Insurance claim denials are being overturned at record rates, signaling that initial denials are often low-fidelity algorithmic 'no's'.
sagaghostwork
Opportunity
94
Confidence
92
Country
Brazil
Market-specific opportunity intelligence for this country, including published evidence, lane clustering, and weekly pulses.
Insurance claim denials are being overturned at record rates, signaling that initial denials are often low-fidelity algorithmic 'no's'.
Walmart is vertically integrating GLP-1 prescribing and fulfillment across 4,600 locations. While they own the supply, patients still struggle with real-time inventory visibility.
The FDA is moving toward easing restrictions on peptides, driven by political pressure for 'longevity' and performance compounds.
New federal rules require 18.5 million adults to prove monthly work hours to keep Medicaid benefits.
FDA unveils rules for bespoke gene therapies, predicting a flood of rare disease applications via a new 'plausible mechanism' pathway.
Abridge is integrating NEJM and JAMA data to move from passive transcription to active clinical decision support.